Help guide our efforts to modernize
Send us your comments by March 14, 2020. Menu
Trial record 1 of 3 for:    Renal Cancer | 936558 | France
Previous Study | Return to List | Next Study

An Observational Study of Nivolumab in Participants With Advanced Kidney Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03455452
Recruitment Status : Recruiting
First Posted : March 6, 2018
Last Update Posted : August 17, 2018
Information provided by (Responsible Party):
Bristol-Myers Squibb

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : January 18, 2022
Estimated Study Completion Date : January 18, 2022